For instance, SIRT6 represses the expressions of the T-box transcription factor 3 (Tbx3) by deacetylation of H3K9ac, which is predictive of poor prognosis in HER2-positive breast cancer patients [15]. Here, TBX3 is linked to breast carcinoma.